You are currently on the new version of our website. Access the old version .
MDPIMDPI

3 Results Found

  • Article
  • Open Access
2,342 Views
15 Pages
Download PDF

Therapeutic Patterns and Clinical Outcomes in Limited Disease Small Cell Lung Cancer: A Decade of Analysis at a Tertiary Cancer Center

  • David Alexander Ziegler,
  • Cecilia Christiane Cleve,
  • Sonia Ziegler,
  • Markus Anton Schirmer,
  • Laura Anna Fischer,
  • Hanibal Bohnenberger,
  • Tobias Raphael Overbeck,
  • Friederike Braulke,
  • Alexander von Hammerstein-Equord and
  • Rami A. El Shafie
  • + 5 authors
Cancers2024, 16(11), 1953;https://doi.org/10.3390/cancers16111953

21 May 2024

In this study, we investigated the outcomes and factors influencing treatment efficacy in 93 patients with limited disease small cell lung cancer (LD-SCLC), with a median age of 64 years. We focused on the impact of chemotherapy regimens, prophylacti...

Full Article
  • Article
  • Open Access
3 Citations
860 Views
11 Pages
Download PDF

Hypofractionated Conformal Radiotherapy in Combination with Chemotherapy in Limited Disease Small Cell Lung Cancer Patients

  • Joanna Socha,
  • Agnieszka Guzowska,
  • Dobromira Tyc-Szczepaniak,
  • Aleksandra Szczęsna and
  • Lucyna Kępka
Adv. Respir. Med.2014, 82(2), 105-115;https://doi.org/10.5603/PiAP.2014.0016

25 February 2014

Aim: To evaluate the results of hypofractionated conformal radiotherapy (RT) in limited disease small cell lung cancer (LD-SCLC) patients, with particular interest in the value of “early” RT, i.e., given before the 3rd chemotherapy (CHT) cycle. Mater...

Full Article
  • Article
  • Open Access
5 Citations
2,590 Views
18 Pages
Download PDF

Validation of Pretreatment Prognostic Factors and Prognostic Staging Systems for Small Cell Lung Cancer in a Real-World Data Set

  • Raphael Hagmann,
  • Alfred Zippelius and
  • Sacha I. Rothschild
Cancers2022, 14(11), 2625;https://doi.org/10.3390/cancers14112625

25 May 2022

Treatment decisions in patients with small cell lung cancer (SCLC) are made based on the extent of the disease. However, the outcome varies among patients at the same stage. A simple tool to predict outcomes in SCLC patients would be helpful for clin...

Full Article